Amgen And Merck Become First Industry Partners Of Academic Clinical Trial Diversity Initiative
By Darren Incorvaia An academic partnership to improve diversity in clinical trials has drafted its first industry team members. Amgen and Merck will help Equitable Breakthroughs in Medicine Development (EQBMED) enroll patients in local clinical trials as part of the partnership’s pilot programme. "Partnering with industry leaders Amgen and Merck is a critical milestone in EQBMED's mission to establish a sustainable clinical trial ecosystem,” associate dean for health equity research and C.N.H Long Professor of Internal Medicine, Public Health and Management at Yale University, Marcella Nunez-Smith, M.D.,said in a Sept....